| Literature DB >> 30135560 |
Shan Bian1, Marko Repic1,2, Zhenming Guo1,3, Anoop Kavirayani4, Thomas Burkard1,5, Joshua A Bagley1, Christian Krauditsch1, Jürgen A Knoblich6.
Abstract
In the originally published paper, the "before" image for the afatinib condition in Fig. 6c was incorrect. Instead of an image displaying a GBM-3 neoplastic organoid before afatinib treatment, this panel showed an image from the GBM-2 control (DMSO) group before treatment. This error has now been corrected in the HTML and PDF versions of the article; the "before, afatinib" panel in Fig. 6c now shows a representative image from the indicated experiment. The color of all error bars in Fig. 6 has also been changed to black, for consistency. All statistical analysis and all conclusions presented in the article are unaffected by this error. Nevertheless, we apologize for the mistake.Entities:
Year: 2018 PMID: 30135560 PMCID: PMC6345371 DOI: 10.1038/s41592-018-0118-8
Source DB: PubMed Journal: Nat Methods ISSN: 1548-7091 Impact factor: 28.547